News Scan for Jan 14, 2022

Insurers may be spending $130 million on ivermectin for COVID-19Needless insurer spending on ivermectin prescriptions for COVID-19, estimated at $2.5 million in the United States for the week of Aug 13, 2021—the most recent week analyzed—would extrapolate to $130 million annually, US researchers reported yesterday in JAMA.Ivermectin has become a hot-button drug because…

Read the full article here

Related Articles